That overemphasis on management has also led to situations where Andani has exited from stocks even when the going is good. Highlighting an instance where the fund pulled the plug on a stock, Andani mentions how they got excited about Omkar Speciality Chemicals, a manufacturer of inorganic and organic intermediates and active pharmaceutical ingredients, which went public in 2011. “It is a good company with strong manufacturing skills, technical know-how and marquee clients. They were coming out of a big capex programme, which meant that return ratios were set for an improvement. We were right about all those factors, but the more we interacted with the management, the more we realised that it was a one-man show and that there was nobody else there apart from the promoter,” says Andani. The company neither had any strong processes in place nor did it have a professional set-up to ensure longevity and sustained growth. “It’s not that we don’t like family structures, but in the absence of professionals, the company could in future very well see its competence erode if outside competition came in and undercut the business. This kind of competitor will not make money but will definitely make the incumbent’s life miserable. In that sense, Omkar looked quite vulnerable,” explains Andani. Since the fund held a significant portion of the mid-cap company’s equity, exiting the counter would have become a challenge if it waited for its assumptions to play out. There was merit in what Andani did, as she could have easily instead overlooked the fact that the stock was minimal as a percentage of assets. But in an absolute sense, at over 8%, the fund held a substantial stake in the company’s equity. “We slowly started exiting the counter once we realised that the thesis by which we had bought the stock no longer held true. Since there was no negative news flow, we were lucky to get out with negligible impact cost within a year’s time, ending up with 25-30% return,” she adds.